Apimeds Pharmaceuticals Q4 EPS $(0.80) Down From $(0.50) YoY

Benzinga Newsdesk www.benzinga.com Negative 95.8%

Neg 95.8% Neu 0% Pos 0%

Apimeds Pharmaceuticals (AMEX:APUS) reported quarterly losses of $(0.80) per share. This is a 60 percent decrease over losses of $(0.50) per share from the same period last year.